| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.39 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |